Sage Therapeutics, Inc. Stock News and Insights on Yahoo Finance
Sage Therapeutics focuses on brain health medicines, including treatments for depression and essential tremors, with ongoing clinical trials.
Sage Therapeutics, Cambridge, Massachusetts, ZULRESSO, ZURZUVAE, depression, clinical trials
Cambridge: So, Sage Therapeutics is making waves in the biopharmaceutical world. They’re all about brain health and have some cool products in the pipeline. One of their big ones is ZULRESSO, which helps with postpartum depression. It’s an injection, and it’s been getting some attention.
Then there’s ZURZUVAE, which is a bit of a mouthful but is designed to target depression too. They’re also working on SAGE-324, which is in Phase II trials for essential tremors. Plus, they’ve got SAGE-718, which is being tested for a bunch of conditions like Alzheimer’s and ADHD.
What’s neat is that they’ve teamed up with Shionogi & Co. to push their products in Japan and a few other places. And they’ve got a partnership with Biogen to develop more treatments. It’s pretty exciting stuff happening over there!
By the way, Sage Therapeutics started out as Sterogen Biopharma back in 2010. They rebranded in 2011 and have been on a mission ever since. If you’re into health innovations, keep an eye on them!
[rule_2]